Penserra Capital Management LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2021$8,088,000
+72.2%
27,989
+15.8%
0.17%
+93.1%
Q1 2021$4,697,000
-33.7%
24,163
-34.7%
0.09%
-47.9%
Q4 2020$7,089,000
+13275.5%
36,998
+8405.3%
0.17%
+4075.0%
Q1 2020$53,000
+89.3%
435
+57.6%
0.00%
+100.0%
Q4 2019$28,000
-99.7%
276
-99.8%
0.00%
-99.7%
Q2 2019$9,502,000110,5650.74%
Other shareholders
REPLIGEN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders